Cost effectiveness of tizanidine and baclofen similar in spasticity

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.381, 2002-01, pp. : 9-9

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost-Effectiveness Comparison of Tizanidine and Baclofen in the Management of Spasticity

By Rushton D.N.

PharmacoEconomics, Vol. 20, Iss. 12, 2002-01 ,pp. : 827-837

Adis International

Access to resources Recommend Favorite

Cost Analysis of the Treatment of Severe Spinal Spasticity With a Continuous Intrathecal Baclofen Infusion System

By Postma M.

PharmacoEconomics, Vol. 15, Iss. 4, 1999-04 ,pp. : 395-404

Adis International

Access to resources Recommend Favorite

Update on tizanidine for muscle spasticity and emerging indications

By Malanga Gerard Reiter Raymond D Garay Edward

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 12, 2008-08 ,pp. : 2209-2215

Informa Healthcare

Access to resources Recommend Favorite

Cost Effectiveness of Oromucosal Cannabis-Based Medicine (Sativex®) for Spasticity in Multiple Sclerosis

By Lu Lanting Pearce Hilary

PharmacoEconomics, Vol. 30, Iss. 12, 2012-12 ,pp. : 1157-1171

Adis International

Access to resources Recommend Favorite

Baclofen/tizanidine: Withdrawal and interaction leading to various toxicities: case report

Reactions Weekly, Vol. 1, Iss. 1344, 2011-01 ,pp. : 8-9

Adis International

Access to resources Recommend Favorite